GGrantIndex
← Search

DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER

$705,038FY2025Defense Health AgencyDOD

Yale Univ

Investigators

View source on USAspending →
DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER · GrantIndex